Close
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population

X
Your article was successfully shared with the contacts you provided.

Objective: To estimate the medical and productivity-related cost burden of systemic lupus erythematosus (SLE) flares and comorbidities in a commercially insured population….

Adjusted annualized indirect costs of work loss because of absence and short-term disability were $1,867 and $1,602 greater, respectively, for SLE patients than for controls.